/
MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

AIM — AIM ImmunoTech Inc.

NYSE American

AIM ImmunoTech Inc.

Back to Screener
$0.19
+0.01(+7.26%)
O
0.18
H
0.19
L
0.18
V
802.44K
⏱️ End-of-day dataAs of Oct 1, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

AIM ImmunoTech Inc. Statistics

Total Valuation

Market Cap$7.45M
Enterprise Value$1.95M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding30.44M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio2.68
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-0.64
EV / Salesn/a
EV / EBITDA-0.88
EV / EBIT-0.72
EV / FCF-0.71

Financial Position

Current Ratio1.01
Quick Ration/a
Debt / Equity0.15
Debt / EBITDA-0.14
Debt / FCF-0.11
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-142.26%
Return on Assets (ROA)-35.21%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-143,952
Employee Count21
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-92.78%
50-Day Moving Average$0.23
200-Day Moving Average$0.60
Relative Strength Index (RSI)31.44
Average Volume (20 Days)4,184,850

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$18.00K
Operating Income-$2.23M
Pretax Income-$3.02M
Net Income-$3.02M
EBITDA-$2.21M
EBIT-$2.72M
Loss Per Share$-0.69

Balance Sheet

Cash & Cash Equivalents$5.82M
Total Debt$315.00K
Net Cash$5.50M
Net Cash Per Share$0.18
Equity (Book Value)$2.13M
Book Value Per Share$0.07
Working Capital$69.00K

Cash Flow

Operating Cash Flow-$3.16M
Capital Expendituresn/a
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$2.75M
FCF Per Share$-0.09

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-36.98%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a